Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
DeepWell Digital Therapeutics (DTx)
Seattle, Washington, United States
- Ownership
- Private
- Development stage
- Other
01
Overview
DeepWell DTx has received FDA clearance for its biofeedback software development kit, designed to reduce stress and hypertension through interactive media like video games. The technology is available over-the-counter and has potential for future indications.
- Therapeutic areas
- CardiovascularNeurologyPsychiatry
- Modalities
- Digital Therapeutics (Software as a Medical Device)
- Industry
- Digital Health Medical Devices
02
Partnerships
Collaborations with media and medical device companiesmember of Digital Therapeutics Alliance
Beyond the preview
Go deeper on DeepWell Digital Therapeutics (DTx).
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on DeepWell Digital Therapeutics (DTx).